ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Tomonori Shirasaka
Tomonori Shirasaka
Other Interests
MICS, Therapy for heart failure(LVAD, Heart transplantation), brain protection in Aortic surgery, root surgery
Research
1. Brain protection ina aortic surgery;
2013 EACTS (European association for cardiothoracic surgery) annual meeting (Vienna, October)
New indicator of postoperative delayed wakening after total aortic arch replacement. Tomonori Shirasaka, Kenji Okada, Hiroya Kano, Takeshi Inoue, Masamichi Matsumori, Yutaka Okita.
2. Novel therapy for heart failure;
A slow-releasing form of Prostacysline agonist (ONO1301SR) enhances endogenous secretion of multiple cardiotherapeutic cytokines and improves cardiac function in rapid-pacing induced canine heart failure model. J Thorac Cardiovasc Surg. 2013 Aug;146(2):413-21. Shirasaka T, Miyagawa S, Fukushima S, Saito A, Shiozaki M, Kawaguchi N, Matsuura N, Nakatani S, Sakai Y, Daimon T, Okita Y, Sawa Y.
2011 American Heart Association, Scientific Session (Orland, Frolida)
Combined therapy of skeletal myoblast cell-sheet transplantation with administration of prostacycline agonist makes left ventricular reverse remodeling on the impaired myocardium in rapid-pacing induced end-stage heart failure in canine heart. Tomonori Shirasaka, Shigeru Miyagawa, Satsuki Fukushima, Satoshi Nakatani, Yutaka Okita, Yoshiki Sawa.
2012 American Heart Association, Scientific Session (Los Angels)
Evidence of improvement in diastolic cardiac function by cell-sheet therapy in a canine dilated cardiomyopathy model. Tomonori Shirasaka, Shigeru Miyagawa, Satsuki Fukushima, Satoshi Nakatani, Yutaka Okita, Yoshiki
Sawa.
Practice Areas
- Thoracic
